Arthritis drug offers children hope
Monday 15 August 2011
A rheumatoid arthritis drug was relaunched in the UK today as a treatment for children whose lives are devastated by a severe form of the disease.
Tocilizumab is the first drug to be specifically licensed for systemic juvenile idiopathic arthritis (sJIA) which affects around 2,500 British youngsters.
The drug was already licensed for the treatment of adults.
Until now sJIA has mostly been treated using anti-inflammatory painkillers and steroid drugs.
Symptoms of the disease include joint pain, fever, enlargement of internal organs and a distinctive salmon-coloured skin rash.
Up to two-thirds of patients develop persistent and chronic arthritis, and half of these suffer significant disability.
Professor Patricia Woo, a rheumatology expert from Great Ormond Street Hospital for Children, said: "Systemic juvenile arthritis can be a devastating disease. It strikes often very young children, causing chronic illness, pain and disability. It is hugely encouraging to have an effective medicine now available to alleviate symptoms, control disease activity and potentially hold back the worst long-term consequences of the disease."
A Phase III trial showed that 71% of children treated with tocilizumab saw a 70% improvement after three months.
Ailsa Bosworth, chief executive of the National Rheumatoid Arthritis Society, said: "Children with sJIA and their families can now look to a future with hope."
Life & Style blogs
Husband creates spreadsheet detailing wife's 'excuses' for turning down sex
Watching TV after work makes you feel 'guilty and like a failure'
NHS medics are being lured away to Australia by more money, status and sunshine, survey suggests
Xiaomi Mi4: 'Chinese Apple' launches flagship mobile to challenge iPhone
Have sex with your iPad thanks to the new sex toy no-one asked for
- 1 Is Gideon Levy the most hated man in Israel or just the most heroic?
- 2 Students offered grants if they tweet pro-Israeli propaganda
- 3 Exclusive: Cameron’s Big Society in tatters as charity watchdog launches investigation into claims of Government funding misuse
- 4 Satellite full of sexually experimental geckos adrift in space, Russia loses control of mission
Highly Competitive Salary: Austen Lloyd: MANCHESTER - Senior Employment Solici...
£600 - £650 per day: Orgtel: Conduct Risk Liaison Manager - Banking - London -...
Highly Attractive Package: Austen Lloyd: CITY - COMMERCIAL LITIGATION - GLOBAL...
£65000 - £75000 per annum + Benefits: Progressive Recruitment: The client is a...